Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Inflammatory pseudotumors (IPTs) are often misdiagnosed as malignant solitary pulmonary nodules (SPNs) because their imaging features overlap with those of malignant SPNs, leading to overtreatment. The purpose of this article was to investigate the value of first-pass enhanced time-to-peak (TTP) in distinguishing IPTs from malignant SPNs using dual-input volume computed tomography perfusion (DI-CTP).

Methods: This retrospective study included consecutive patients from No. 82 Group Hospital of Chinese People's Liberation Army with IPTs or malignant SPNs by surgery or biopsy from June 2016 to October 2021. Pulmonary artery flow (PF), bronchial artery flow (BF), perfusion index (PI), time-density curve, total perfusion (TLP), and first-pass TTP for all SPNs were determined by DI-CTP. The receiver operating characteristic (ROC) curve was used to analyse the values of TTP and other perfusion parameters in the differential diagnosis of IPTs and malignant SPNs.

Results: Ninety-eight patients were enrolled, including 25 with IPTs and 73 with malignant SPNs. The intraclass correlation coefficient (ICC) for inter-observer and intra-observer reliability of all parameters was perfect (all ICCs >0.90, P<0.01). Compared with IPTs, the malignant SPNs showed significantly higher PF, TLP, and TTP (all P<0.01), without significant differences in BF and PI (all P>0.05). The area under the curve of TTP was 0.987, which was higher than those of the other perfusion parameters (0.987 0.752 0.609 0.728 0.628). With a cut-off TTP of 18.10 s to distinguish IPNs from malignant SPNs, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 92.0%, 97.3%, 97.3%, 96.0%, and 96.9%, respectively. The sensitivity, specificity, and accuracy of CT plain scan combined with DI-CTP in diagnosing pulmonary nodules were 100%, 96.83%, and 98.97%, respectively.

Conclusions: Compared with other perfusion parameters, TTP may be a more valuable parameter to differentiate IPTs from malignant SPNs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11994533PMC
http://dx.doi.org/10.21037/qims-24-1261DOI Listing

Publication Analysis

Top Keywords

malignant spns
16
ipts malignant
16
inflammatory pseudotumors
8
pulmonary nodules
8
dual-input volume
8
volume computed
8
artery flow
8
malignant
7
spns
6
ipts
5

Similar Publications

The added value of quantitative contrast-enhanced CT parameters in distinguishing malignant from benign solid pulmonary nodules.

BMC Med Imaging

July 2025

Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.

Purpose: To explore the added value of quantitative parameters derived from routine chest contrast-enhanced computed tomography (CECT) in distinguishing malignant from benign solid pulmonary nodules (SPNs).

Methods: Eighty-one SPNs pathologically confirmed as benign or malignant with preoperative nonenhanced chest and CECT scans were retrospectively analyzed. Quantitative parameters [CT attenuation value of nonenhanced phase (AV), value of arterial phase (AV), value of venous phase (AV), their differentials (△AV, △AV, △AV), diameter] and qualitative CT features [lobulation, spiculation, vacuolar sign, pleural depression sign, vascular convergence, edge clarity] were obtained.

View Article and Find Full Text PDF

Background: The characterization of solitary pulmonary nodules (SPNs) as malignant or benign remains a diagnostic challenge using conventional imaging parameters. The literature suggests using combined Positron Emission Tomography (PET) and Computed Tomography (CT) to characterise a SPN. Radiomics and machine learning are other promising technologies which can be utilised to characterise the SPN.

View Article and Find Full Text PDF

Cascade Energy Transformation in Hybrid Nanosensitizer Enables Ultrasound-Activated Luminescence Imaging and Enhanced Sonodynamic Therapy.

J Am Chem Soc

July 2025

State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, P. R. China.

Optical imaging plays a pivotal role in the diagnosis and management of cancer, yet conventional techniques often suffer from limitations such as tissue autofluorescence, insufficient imaging depth, and signal persistence. Here, we introduce a hybrid nanosensitizer, SPNs(SP1)@CoOOH, that leverages cascade energy transformation (ultrasonic → chemical → photonic energy) to enable ultrasound-activated luminescence imaging concomitant with enhanced sonodynamic therapy (SDT). By integrating semiconducting polymer nanoparticles (SPNs) with cobalt oxide hydroxide (CoOOH), our platform facilitates dual-pathway reactive oxygen species (ROS) generation under acidic and ultrasound costimulation.

View Article and Find Full Text PDF

Background: Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare low-grade malignant tumor. Conventional pancreatic resection (CP) can severely compromise pancreatic function, whereas enucleation (EN), a pancreas-preserving technique, has gradually gained traction in pediatric patients. This study aimed to compare the outcomes of enucleation (EN) and conventional pancreatic resection (CP) in pediatric patients with SPNs.

View Article and Find Full Text PDF

Extracellular matrix-degradable polymer nanostimulants elicit potent immune responses in orthotopic pancreatic cancer via sono-activatable dual-drug synergism.

Mater Today Bio

August 2025

State Key Laboratory of Advanced Fiber Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai, 201620, China.

Pancreatic cancer is a highly aggressive malignancy with a poor prognosis due to its complex tumor microenvironment (TME), which includes a dense extracellular matrix (ECM) and immunosuppressive pathways. Nanomedicine capable of achieving profound tumor penetration and modulating the tumor immune microenvironment is urgently needed to enhance the efficacy of cancer therapy. Herein, we introduce ECM-degradable semiconducting polymer nanostimulants (SPNs) as a novel nanostimulant for deep tumor penetration and multifaceted remodeling of the tumor microenvironment.

View Article and Find Full Text PDF